Registry data as of Aug 27, 2026

Thomas Gliko

Pharmacist · Seattle, WA

Thomas Gliko is a pharmacist with a practice address in Seattle, Washington, and NPI 1750505186, issued on Apr 13, 2007. Check the license (Washington PH0003994, as entered in NPPES) with the Washington board that licenses this profession; the Medicare figures below come from public CMS files.

Record from CMS NPPES, loaded Aug 27, 2026 · Medicare files 2023 and 2024 · method · Verify with CMS →

NPPES recordas of Aug 27, 2026
1750505186
Name
Thomas Gliko
Primary taxonomy
Pharmacist 183500000X
License number
PH0003994 WA
Self-reported in NPPES; status is on the state search
Practice location
3207 45TH Ave SW, Seattle, WA 98116
Phone
(800) 282-6191
Enumerated
Apr 13, 2007
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). A record is not a license: verify it with the state board.
Download card Updates feed

Verify Thomas Gliko in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersWhich Washington board licenses this profession
    Search for license PH0003994
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS, AOA, NCCPA, AANPNot checked
Find the Washington license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

84% fewer Medicare Part D claims than the average pharmacist in 2024

20 Medicare Part D claims for 14 beneficiaries, against an average of 127 among the 28,933 providers of this specialty who prescribed in Part D.

  1. Thomas Gliko20
  2. Specialty average127

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

1,490 pharmacist records list a Seattle practice address

They are 1,490 of the 41,956 NPPES records with a Seattle practice address, and 7,880 pharmacist records in Washington.

Other pharmacist records in Washington

  1. Steven AahlBothell, WA1477691137
  2. Jon Aal, RPHOlympia, WA1457753212
  3. Kenric Aalund-NelsonBellingham, WA1033944996
  4. Kevin Aardal, RXTRichland, WA1932810298
  5. Rania Abaza, PHARMDVancouver, WA1699660258
  6. Roomi Abbas, RPHKenmore, WA1457293292
  7. Marvin Abbott, PHARMACISTOlympia, WA1053550384
  8. Doaa Abdelazeez, RPHLynden, WA1184153074
  9. John AbdelmalekAberdeen, WA1881985133
  10. Shorooq AbdelqaderSeattle, WA1528638889

Common questions

What is Thomas Gliko's NPI number?

Thomas Gliko's National Provider Identifier (NPI) is 1750505186, issued on Apr 13, 2007. An NPI identifies a provider in billing; it is not a license.

Where is Thomas Gliko located?

The NPPES record lists a practice address at 3207 45TH Ave SW, Seattle, WA, 98116. Phone: (800) 282-6191. Providers update this record themselves, so call before visiting.

How can I verify Thomas Gliko's license?

NPPES lists Washington license number PH0003994, as entered by the provider. Search the Washington board that licenses this profession; the NPPES record confirms identity only.

How much does Thomas Gliko prescribe under Medicare Part D?

In 2024, Thomas Gliko had 20 Medicare Part D claims for 14 beneficiaries; the average among pharmacist prescribers was 127. Part D covers Medicare prescriptions only.

Source: CMS National Plan and Provider Enumeration System (NPPES), loaded Aug 27, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 27, 2026.